Treatment options for Vulvovaginal Candidiasis, 1993

Clinical Infectious Diseases

Volumn 20, Issue , 1995, Pages

  Reef, Susan E ^a,b,c,d,e   Levine, William C ^a,b,c,d,e   Mc Neil, Michael M ^a,b,c,d,e   Fisher Hoch, Susan ^a,b,c,d,e   Holmberg, Scott D ^a,b,c,d,e   Duerr, Ann ^a,b,c,d,e   Smith, Dawn ^a,b,c,d,e   Sobel, Jack D ^a,b,c,d,e   Pinner, Robert W ^a,b,c,d,e  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b National Center for Prevention Services ^*  (United States)

^c National Center for Infectious Diseases ^*  (United States)

^d AGA KHAN UNIVERSITY   (Pakistan)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFUNGAL AGENT; ASPARTATE AMINOTRANSFERASE; ASTEMIZOLE; BUTOCONAZOLE; CLOTRIMAZOLE; COUMARIN; CYCLOSPORIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; LIVER ENZYME; MICONAZOLE; NYSTATIN; PHENYTOIN; RIFAMPICIN; TERCONAZOLE; TERFENADINE; TIOCONAZOLE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; LIVER TOXICITY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VAGINA CANDIDIASIS;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIBIOTICS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HIV INFECTIONS; HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECURRENCE;

EID: 0028911741     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.Supplement_1.S80     Document Type: Article

References (97)

1. Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990;74:1573-602.
2. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165(4 suppl 2): 1168-76.
3. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152(7 suppl 2):924-35.
4. Kinghom GR. Vulvovaginal candidosis. J Antimicrob Chemother 1991;28(suppl A): 59-66.
5. Odds FC. Candida and candidosis. 2nd ed. London: Bailliere Tindall, 1988:124-35.
6. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14(suppl 1):S148-53.
7. O’Connor MI, Sobel JD. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans. J Infect Dis 1986; 154:358-63.
8. Witkin SS. Immunologic aspects of recurrent vaginitis. In: Horowitz BJ, Märdh PA, eds. Vaginitis and vaginosis. 1st ed. New York: Wiley- Liss, 1991:247-50.
9. Hankins CA, Handley MA. HIV disease and AIDS in women: current knowledge and a research agenda. J Acquir Immune Defic Syndr 1992;5:957-71.
10. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7.
11. Imam N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-6.
12. Duerr A, Kelly P, DeHovitz J, et al. Gynecologic conditions in HIV-infected women in Brooklyn, New Yprk [abstract no PoB 3051, B95]. In: Program and abstracts of the 8th International Conference on AIDS (Amsterdam). Vol 2. Amsterdam: CONGREX Holland BV, 1992.
13. Kent HL. New therapy for vulvovaginal candidiasis. In: Horowitz BJ, Märdh PA, eds. Vaginitis and vaginosis. New York: Wiley-Liss, 1991:257-68.
14. Wolfson N, Samuels B, Hodgson C, Graves K. One-day management of vulvovaginal candidiasis. J La State Med Soc 1987; 139:27-9.
15. Lebherz T, Guess E, Wolfson N. Efficacy of single- versus multiple- dose clotrimazole therapy in the management of vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152(7 suppl 2):965-8.
16. Fleury F, Hughes D, Floyd R. Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol 1985; 152(7 suppl 2):968-70.
17. Loendersloot EW, Goormans E, Wiesenhaan PE, Barthel PJ, Branolte JH. Efficacy and toierability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole. Am J Obstet Gynecol 1985; 152(7 suppl 2):953-5.
18. Goorsmans E, Bergstein NAM, Loendersloot EW, Branolte JH. One- dose therapy of Candida vaginitis. Chemotherapy 1982;28(suppl 1): 106-9.
19. Wolfson N, Samuels B, Riley J. A three-day treatment regimen for vulvovaginal candidiasis. J La State Med Soc 1982; 134:28-31.
20. Couchman JM. A preliminary report on a trial of clotrimazole against vaginal candidiasis in venereology. Postgrad Med J 1974; 50(suppl):93-4.
21. Oates JK, Davidson F. Treatment of vaginal candidiasis with clotrimazole. Postgrad Med J 1974;50(suppl):99-102.
22. Lebherz TB, Ford LC, Kleinkopf V. A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis. Clin Ther 1981;3:355-8.
23. Robertson WH. Vulvovaginal candidiasis treated with clotrimazole cream in seven days compared with fourteen-day treatment with miconazole cream. Am J Obstet Gynecol 1978; 132:321-3.
24. Franklin R. Seven-day clotrimazole therapy for vulvovaginal candidiasis. South Med J 1978;71:141-3.
25. Mayron J. Clotrimazole for vulvovaginal candidiasis: report of doubleblind study. NY State J Med 1977;77:1732-3.
26. Lebherz TB, Goldman L, Wiesmeier E, Mason D, Ford LC. A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use. Clin Ther 1983;5:409-16.
27. Pasquale SA, Lawson J, Sargent EC Jr, Newdeck JP. A dose-response study with Monistat cream. Obstet Gynecol 1979;53:250-3.
28. Bentley S, Bourne MS, Powell A. A comparative study of miconazole nitrate pessaries and Nystatin vaginal tablets in the treatment of vaginal candidiasis. Br J Clin Pract 1978;32:258-9.
29. Corson SL, Kapikian RR, Nehring R. Terconazole and miconazole cream for treating vulvovaginal candidiasis. J Reprod Med 1991;36:561-7.
30. Thomason JL, Gelbart SM, Kellett AV, Scaglione NJ, Gotwalt KT, Broekhuizen FF. Terconazole for the treatment of vulvovaginal candidiasis. J Reprod Med 1990;35:992-4.
31. Kjaeldgaard A. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis. Pharmatherapeu- tica 1986;4:525-31.
32. Stein GE, Gurwith D, Mummaw N, Gurwith M. Single-dose tiocona- zole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis. Antimicrob Agents Chemother 1986;29:969-71.
33. Kaufman RH, Henzl MR, Brown D Jr, et al. Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. J Reprod Med 1989;34:479-83.
34. Droegemueller W, Adamson DG, Brown D, et al. Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. Obstet Gynecol 1984;64:530-4.
35. Jacobson JB, Hajman AJ, Wiese J, Gandrup P, Forsstrom S. A new vaginal antifungal agent—butoconazole nitrate. Acta Obstet Gynecol Scand 1985;64:241-4.
36. Hajman AJ. Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment of 1% clotrimazole cream. J Int Med Res 1988; 16:367-75.
37. Adamson GD, Brown D Jr, Standard JV, Henzl MR. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis. J Reprod Med 1986;31:131-2.
38. Brown D Jr, Henzl MR, LePage ME, et al. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis: comparison with miconazole nitrate and placebo. J Reprod Med 1986;31:1045-8.
39. Bradbeer CS, Mayhew SR, Barlow D. Butoconazole and miconazole in treating vaginal candidiasis. Genitourin Med 1985;61:270-2.
40. Bro F. Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis. J Fam Pract 1990;31:148-52.
41. Masterton G, Henderson J, Napier IR, Moffet M. Six-day clotrimazole therapy in vaginal candidosis. Curr Med Res Opin 1975;3:83-8.
42. Higashide K, Kawaguchi C, Tomoda Y. Three-day clotrimazole therapy for vulvo-vaginal mycosis. J Int Med Res 1983; 11:21-7.
43. Mizuno S, Cho N. Clinical evaluation of three-day treatment of vaginal mycosis with clotrimazole vaginal tablets. J Int Med Res 1983;11:179-85.
44. Multicenter Study Group. Treatment of vaginal candidiasis with a single oral dose of fluconazole. Eur J Clin Microbiol Infect Dis 1988;7:364-7.
45. Stein GE, Christensen S, Mummaw N. Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. DICP 1991;25:582-4.
46. Kutzer E, Oittner R, Leodolter S, Brammer KW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicenter trial. Eur J Obstet Gynecol Reprod Biol 1988;29:305-13.
47. Multicentre Study Group. A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial. Br J Obstet Gynaecol 1989;96:226-32.
48. Bloch B, Smythe E. Ketoconazole in the treatment of vaginal candidiasis. S Afr Me, d J 1985; 67:178-9.
49. van der Pas H, Peeters F, Janssens D, Snauwaert E, van Cutsem J. Treatment of vaginal candidosis with oral ketoconazole. Eur J Obstet Gynecol Reprod Biol 1983; 14:399-404.
50. Rohde-Wemer MH. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis. J Int Med Res 1984; 12:298-302.
51. Puolakka J, Tuimala R. A comparison between oral ketoconazole and topical miconazole in the treatment of vaginal candidiasis. Acta Obstet Gynecol Scand 1983;62:575-7.
52. Bingham JS. Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and \% cream in treating acute vaginal candidosis. Br J VenerDis 1984;60:175-7.
53. Kovacs GT, Westcott M, Rusden J. A prospective study to assess the efficacy of ketoconazole in the treatment of recurrent vaginal candidiasis. Med J Aust 1990; 153:326-330.
54. Miller PI, Humphries M, Grassick K. A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice. Pharmatherapeutica 1984;3:582-7.
55. Cauwenbergh G. Itraconazole: the first orally active antifungal for single-day treatment of vaginal candidiasis. Curr Ther Res 1987; 41:210-4.
56. Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother 1993;37:89-92.
57. Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Gentourin Med 1992;68:36-8.
58. Calderon-Marquez JJ. Itraconazole in the treatment of vaginal candidosis and the effect of treatment of the sexual partner. Rev Infect Dis 1987;9(suppl l):S143-5.
59. Silva-Cruz A, Andrade L, Sobral L, Francisca A. Itraconazole versus placebo in the management of vaginal candidiasis. Int J Gynaecol Obstet 1991;36:229-32.
60. Sanz Sanz F, del Palacio Hernanz A. Randomized comparative trial of three regimens of itraconazole for treatment of vaginal mycoses. Rev Infect Dis 1987;9(suppl l):S139-42.
61. Boag FC, Houang ET, Westrom R, McCormack SM, Lawrence AG. Comparison of vaginal flora after treatment with clotrimazole 500 mg vaginal pessary or a fluconazole' 150 mg capsule for vaginal candidosis. Genitourin Med 1991;67:232-4.
62. McNellis D, McLeod M, Lawson J, Pasquale SA. Treatment of vulvovaginal candidiasis in pregnancy. Obstet Gynecol 1977;50:674-8.
63. Lindeque BG, van Niekerk WA. Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary. S Afr Med J 1984;65:123-4.
64. Dunster GD. Vaginal candidiasis in pregnancy—a trial of clotrimazole. Postgrad Med J 1974;50:86-8.
65. Tan CG, Milne LJR, Good CS, Loudon JDO. A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis. Postgrad Med J 1974;50(suppl): 102-5.
66. Weisberg M. Treatment of vaginal candidiasis in pregnant women. Clin Ther 1986;8:563-7.
67. Goormans E. Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis. Gynakol Rundsch 1985;25(suppl l):74-82.
68. Haram K, Digranes A. Vulvovaginal candidiasis in pregnancy treated with clotrimazole. Acta Obstet Gynecol Scand 1978;57:453-5.
69. Frerich W, Gad A. The frequency of Candida infections in pregnancy and their treatment with clotrimazole. Curr Med Res Opin 1977;4:640-4.
70. Wallenburg HCS, Wladimiroff JW. Recurrence of vulvovaginal candidosis during pregnancy. Obstet Gynecol 1976;48:491-4.
71. Sobel JD, Schmitt C, Meriwether C. Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis. Obstet Gynecol 1989; 73(3 suppl l):30-4.
72. Sobel JD. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-8.
73. Roth AC, Milsom I, Forssman L, Wahlen P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med 1990;66:357-60.
74. Van Heusden AM, Merkus JMWM. Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant. Eur J Obstet Gynecol 1990;35:75-83.
75. Sobel JD. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985;65:435-40.
76. Davidson F, Mould RF. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis 1978;54:176-83.
77. Eschenbach DA, Hummel D, Gravett MG. Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole. Obstet Gynecol 1985;66:248-54.
78. Bushell TE, Evans EG, Meaden JD, Milne JD, Wamock DW. Intermittent local prophylaxis against recurrent vaginal candidosis. Gentourin Med 1988;64:335-8.
79. Balsdon MJ, Tobin JM. Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment. Genitourin Med 1988;64:124-7.
80. Bushell TEC, Evans EGV, Llewellyn PA, Meaden JD, Milne JD, War- nock DW. Prophylactic use of clotrimazole in recurrent vaginal candidosis. Ann NY Acad Sci 1988;544:558-60.
81. Nightingale SL. Clotrimazole available without prescription for vaginal yeast infections. JAMA 1991;265:182.
82. Cusack WE Jr. Miconazole nitrate three-day vaginal suppositories vs seven-day vaginal cream: the multicenter results. Proceedings from a meeting held in Boca Raton, Florida. Raritan, New Jersey: Ortho Pharmaceutical Corporation, 1984:10-2.
83. Drug topics red book. 97th ed. Montvale, New Jersey: Medical Economics, 1993.
84. Tatum DM, Eggleston M. Butoconazole nitrate. Infect Control Hosp Epidemiol 1988;9:122-4.
85. Abramowicz M. Topical drugs for vaginal candidiasis. Med Lett Drugs Ther 1991;33:81.
86. Ritter W. Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. Am J Obstet Gynecol 1985; 152:945-7.
87. Clissold SP, Heel RC. Tioconazole: a review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs 1986;31:29-51.
88. Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynaecol Obstet 1992;37(suppl 1): 17-24.
89. Sobel JD. Individualizing treatment of vaginal candidiasis. J Am Acad Dermatol 1990;23(3 part 2):572-6.
90. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116:353-7.
91. Levy DA, Bohbot JM, Catalan F, Normier G, Pinel AM, d’Hinterland LD. Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis. Vaccine 1989;7:337-40.
92. Dennerstein GJ. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med 1986; 1:801-3.
93. Mc Cutchan JA, Ronald AR, Corey L, Handsfield HH. Evaluation of new anti-infective drugs for the treatment of vaginal infections. Clin Infect Dis 1992; 15(suppl 1):S115-22.
94. Bluestein D, Rutledge C, Lumsden L. Predicting the occurrence of antibiotic-induced candidal vaginitis. Fam Pract Res J 1991; 11:319-26.
95. Patel HS, Peters MD, Smith CL. Is there a role for fluconazole in the treatment of vulvovaginal candidiasis? Ann Pharmacother 1992;26:350-3.
96. Merkus JMWM. Treatment of vaginal candidiasis: orally or vaginally? J Am Acad Dermatol 1990;23:568-72.
97. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993;31:2933-7.